SU637086A3 - Method of obtaining purine derivatives, or their acid-additive salts or alkali metal salts - Google Patents
Method of obtaining purine derivatives, or their acid-additive salts or alkali metal saltsInfo
- Publication number
- SU637086A3 SU637086A3 SU772455681A SU2455681A SU637086A3 SU 637086 A3 SU637086 A3 SU 637086A3 SU 772455681 A SU772455681 A SU 772455681A SU 2455681 A SU2455681 A SU 2455681A SU 637086 A3 SU637086 A3 SU 637086A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- general formula
- alkali metal
- compound
- hydrogen
- salts
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Description
сацию пурина общей формулы (II), где Q- водород, с соединением общей формулы (III), где А - галоид, в ирисутствии основани , например гидрида иатри .Cation of purine of the general formula (II), where Q is hydrogen, with a compound of the general formula (III), where A is halogen, in the presence of a base, for example, iatri hydride
Пример 1. Получение 9- (2-пропионоилоксиэтоксиметил )-гуанина.Example 1. The preparation of 9- (2-propionoyloxyethoxymethyl) -guanine.
A.31 2 этиленгли:кол , 18,5 г пропионовой кислоты и 7,5 г сильной ионоводородной смолы Био Род АС 50 Х-4 в 100 мл толуола орошают при перемешивании иод ловушкой Дина Старка в течение 18 ч. Затем мгновенным испарением удал ют толуол и оставшуюс жидкость дистиллируют. За начальным головным погоном зтиленгликол иолучают дистилл т желаемого продукта - этиленгликоль моиопропионата. Выход 70%.A.31 2 ethylene glycers: cola, 18.5 g of propionic acid and 7.5 g of Bio Rhode AC 50 X-4 strong ion hydrogen resin in 100 ml of toluene are irrigated with stirring, the iodine is trapped for 18 hours by instant evaporation. the toluene and the remaining liquid are distilled. Behind the initial head strap, the glycol glycol is distilled and the distillate of the desired product is obtained — ethylene glycol myopropionate. Yield 70%.
Б. Сухой хлористый водород иропускают в охлажденную (0°С) суспензию 7,1 г этиленгликол монопроииопата, полученную выше, и 1,8 г параформальдегида в 50 мл дихлорметада, пока осадок не растворитс в смеси, насыщеиной хлористым водородом . После высушивани над молекул рными ситам.и и хлоридом кальци смесь отфильтровывают и растворитель удал ют мгиовенным выпариванием при 30° С. Оставшеес масло 2-пропионоилоксиэтоксиметилхлорида используют далее непосредственно . Выход 60%.B. Dry hydrogen chloride is sprinkled into a cooled (0 ° C) suspension of 7.1 g of ethylene glycol monopropane prepared above and 1.8 g of paraformaldehyde in 50 ml of dichloromethane until the residue dissolves in a mixture saturated with hydrogen chloride. After drying over molecular sieves. And calcium chloride, the mixture is filtered and the solvent is removed by immediate evaporation at 30 ° C. The remaining 2-propionoyloxyethoxymethyl chloride oil is then used directly. Yield 60%.
B.2,53 г гидрида натри в 57%-ной минеральной масл ной дисперсии промывают сухим гексаном и добавл ют к раствору 4,53 г гуанина в 100 мл сухого диметилсульфоксида , после чего смесь перемешивают при 30° С в течение 23 ч. Затем добавл ют 5,5 г 2-пропионоилоксиэтоксиметилхлорида и реакционную смесь перемешивают при 20° С в течеиие 18 ч. Раствор отфильтровывают И растворитель удал ют мгновенным выпариванием в вакууме. Остаток охлаждают на лед ной бане, раствор ют в воде и нейтрализуют уксусной кислотой. После выдерживани в течение 1 ч продукт отфильтровывают , промывают водой и сушат. Перекристаллизацией (3 раза) из кип щего ацетонитрила получают 9-(2-пропионоилоксиэтоксиметил )-гуанин. Выход 35%, 223-226° С.B.2.53 g of sodium hydride in 57% mineral oil dispersion is washed with dry hexane and 4.53 g of guanine in 100 ml of dry dimethyl sulfoxide is added to the solution, after which the mixture is stirred at 30 ° C for 23 hours. 5.5 g of 2-propionoyloxyethoxymethyl chloride are added and the reaction mixture is stirred at 20 ° C for 18 hours. The solution is filtered and the solvent is removed by instant evaporation in vacuo. The residue is cooled in an ice bath, dissolved in water and neutralized with acetic acid. After standing for 1 hour, the product is filtered, washed with water and dried. Recrystallization (3 times) from refluxing acetonitrile gives 9- (2-propionoyloxyethoxymethyl) -guanine. Yield 35%, 223-226 ° C.
Пример 2. Получение 9- (2-додеканоилоксиэтоксиметил )-2,6-диаминопурина.Example 2. Getting 9- (2-dodecanoyl) ethoxy) -2,6-diaminopurine.
Сухой хлористый водород пропускают в охлажденную (0°С) суспензию 14,66 этилеигликольмопододеконата и 1,8 г параформальдегида в 50 мл дихлорметана, пока твердые частицы не раствор тс , а затем смесь насыщают хлористым водородом. После высушивани раствора над молекул рными ситами и хлористым кальцием смесь отфильтровывают и растворители удал ют мгиовенным испарением при 30° С. Оставшеес масло 2-додеканоилоксиэтоксиметилхлорида использзют далее непосредственно . Выход 75%.Dry hydrogen chloride is passed to a cooled (0 ° C) suspension of 14.66 ethylene glycol pre-dodeconate and 1.8 g of paraformaldehyde in 50 ml of dichloromethane until the solids dissolve and then the mixture is saturated with hydrogen chloride. After the solution was dried over molecular sieves and calcium chloride, the mixture was filtered and the solvents were removed by immediate evaporation at 30 ° C. The remaining 2-dodecanoyl-oxyethoxymethyl chloride oil was then used directly. 75% yield.
Безводный оаствоп 2.6-пиаминопупина RAnhydrous solution 2.6-piaminopupina R
диметилформамиде готов т нагреванием 3,54 г моногидрата в 250 мл растворител па паровой бане до растворени , охлаждают и оставл ют сто ть дл испарени вdimethylformamide is prepared by heating 3.54 g of the monohydrate in a 250 ml of solvent in a steam bath until dissolved, cooled and left to stand to evaporate in
течение 18 ч.for 18 hours
К смеси добавл ют 0,95 г 57%-ной минеральной масл ной дисперсии гидрида натри . После перемешивани сусиензии в течеиие ночи капельным путем добавл ютTo the mixture was added 0.95 g of a 57% mineral oil dispersion of sodium hydride. After stirring the suspension for overnight, add
6,35 г 2-додеканоилоксиэтокоиметилхлорида и реакционную смесь перемешивают при окружающей температуре в течение ночи. Твердые частицы отфильтровывают, промывают хлороформом, объединенные промывки и маточный раствор выпаривают при 60° С. Оставшеес масло перекриеталлизовывают из этанола. Выход 20%.6.35 g of 2-dodecanoyl-oxo-ethomethyl chloride and the reaction mixture is stirred at ambient temperature overnight. The solids are filtered, washed with chloroform, the combined washes and the mother liquor is evaporated at 60 ° C. The remaining oil is recrystallized from ethanol. Yield 20%.
Claims (3)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB7988/76A GB1561380A (en) | 1976-03-01 | 1976-03-01 | Esters of hydroxyalkoxyalkyl purines their preparation and pharmaceutical compositions containing them |
US71810576A | 1976-08-27 | 1976-08-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
SU637086A3 true SU637086A3 (en) | 1978-12-05 |
Family
ID=26241801
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SU772455681A SU637086A3 (en) | 1976-03-01 | 1977-03-01 | Method of obtaining purine derivatives, or their acid-additive salts or alkali metal salts |
Country Status (25)
Country | Link |
---|---|
JP (1) | JPS52106896A (en) |
AR (4) | AR228232A1 (en) |
AT (1) | AT361007B (en) |
AU (1) | AU515553B2 (en) |
BE (1) | BE851972R (en) |
BG (2) | BG27750A3 (en) |
CA (1) | CA1086316A (en) |
CH (4) | CH629806A5 (en) |
DD (1) | DD128611A5 (en) |
DE (1) | DE2708827A1 (en) |
DK (1) | DK147824C (en) |
ES (1) | ES456432A2 (en) |
FI (1) | FI60710C (en) |
FR (1) | FR2342972A2 (en) |
GR (1) | GR66070B (en) |
HU (1) | HU176907B (en) |
IE (1) | IE44708B1 (en) |
IT (1) | IT8048953A0 (en) |
LU (1) | LU76869A1 (en) |
NL (2) | NL7702175A (en) |
PL (2) | PL115242B1 (en) |
RO (1) | RO76591A (en) |
SE (1) | SE433216B (en) |
SU (1) | SU637086A3 (en) |
ZA (1) | ZA771220B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL8202626A (en) * | 1982-06-29 | 1984-01-16 | Stichting Rega V Z W | DERIVATIVES OF 9- (2-HYDROXYETHOXYMETHYL) GUANINE. |
ES8403904A1 (en) * | 1983-02-25 | 1984-04-01 | Ind Farma Especial | Process for the preparation of acycloguanosine |
GB8816760D0 (en) * | 1988-07-14 | 1988-08-17 | Wellcome Found | Therapeutic compounds |
JP4704223B2 (en) * | 2006-01-30 | 2011-06-15 | Hoya株式会社 | Lead screw mechanism |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5122049A (en) * | 1974-08-19 | 1976-02-21 | Sanwa Denki Kk | KAHENTEIKO SOCHI |
-
1977
- 1977-02-28 AU AU22759/77A patent/AU515553B2/en not_active Expired
- 1977-03-01 RO RO7796630A patent/RO76591A/en unknown
- 1977-03-01 JP JP2211377A patent/JPS52106896A/en active Granted
- 1977-03-01 FI FI770655A patent/FI60710C/en not_active IP Right Cessation
- 1977-03-01 ZA ZA00771220A patent/ZA771220B/en unknown
- 1977-03-01 SE SE7702233A patent/SE433216B/en not_active IP Right Cessation
- 1977-03-01 LU LU76869A patent/LU76869A1/xx unknown
- 1977-03-01 CA CA272,888A patent/CA1086316A/en not_active Expired
- 1977-03-01 PL PL1977211568A patent/PL115242B1/en unknown
- 1977-03-01 PL PL1977196356A patent/PL115267B1/en not_active IP Right Cessation
- 1977-03-01 NL NL7702175A patent/NL7702175A/en active Search and Examination
- 1977-03-01 DE DE19772708827 patent/DE2708827A1/en active Granted
- 1977-03-01 DD DD197619A patent/DD128611A5/en unknown
- 1977-03-01 HU HU77WE550A patent/HU176907B/en not_active IP Right Cessation
- 1977-03-01 IE IE438/77A patent/IE44708B1/en unknown
- 1977-03-01 AR AR266728A patent/AR228232A1/en active
- 1977-03-01 BG BG035556A patent/BG27750A3/en unknown
- 1977-03-01 FR FR7705924A patent/FR2342972A2/en active Granted
- 1977-03-01 BE BE175383A patent/BE851972R/en not_active IP Right Cessation
- 1977-03-01 BG BG036534A patent/BG28067A3/en unknown
- 1977-03-01 GR GR52881A patent/GR66070B/el unknown
- 1977-03-01 DK DK88677A patent/DK147824C/en not_active IP Right Cessation
- 1977-03-01 SU SU772455681A patent/SU637086A3/en active
- 1977-03-01 ES ES456432A patent/ES456432A2/en not_active Expired
- 1977-03-01 AT AT134877A patent/AT361007B/en not_active IP Right Cessation
- 1977-03-01 CH CH257177A patent/CH629806A5/en not_active IP Right Cessation
-
1980
- 1980-06-12 IT IT8048953A patent/IT8048953A0/en unknown
-
1981
- 1981-07-24 AR AR286219A patent/AR228282A1/en active
- 1981-07-24 AR AR286220A patent/AR228283A1/en active
- 1981-07-24 AR AR286218A patent/AR228281A1/en active
- 1981-08-31 CH CH558581A patent/CH631176A5/en not_active IP Right Cessation
- 1981-08-31 CH CH558681A patent/CH632757A5/en not_active IP Right Cessation
- 1981-08-31 CH CH558781A patent/CH632758A5/en not_active IP Right Cessation
-
1984
- 1984-03-21 NL NL8400896A patent/NL8400896A/en not_active Application Discontinuation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Baker et al. | 73. Cyclic meso-ionic compounds. Part I. The structure of the sydnones and related compounds | |
SU686618A3 (en) | Method of producing purine derivatives or their salts | |
DK159680B (en) | CYCLIC IMIDES USED FOR THE PREPARATION OF CYCLIC AMINO ACIDS | |
SU637086A3 (en) | Method of obtaining purine derivatives, or their acid-additive salts or alkali metal salts | |
US3979379A (en) | Process for producing 1,3,5,7-tetraalkanoyl-1,3,5,7-octahydrotetrazocines | |
SU558644A3 (en) | The method of obtaining imidazoles or their salts | |
SU541429A3 (en) | The method of obtaining derivatives of 3-alkyl-4-sulfamoylaniline or their salts | |
SU564813A3 (en) | Method for obtaining derivatives of indoloquinolysine or their salts | |
US3029239A (en) | Basic substituted 1-and 7-alkylxanthines or salts thereof | |
US3265565A (en) | Preparation and fungicidal use of tetracyanodithiadiene | |
US2829157A (en) | Novel hydantoic acids and their alkyl esters | |
US3689502A (en) | Preparation of n-(2-alkylthioethyl) nitroimidazoles | |
SU481153A3 (en) | The method of obtaining cyanophenoxyacetonitriles | |
GB823068A (en) | Condensation products from glucosides | |
Sammis | THE ACTION OF MERCAPTIDES ON QUINONES. | |
Gill et al. | The synthesis and characterisation of some 2, 7‐diazaphenanthrene derivatives | |
JPS5936638B2 (en) | Method for producing bisdithiolium salts | |
Winters et al. | Reactions of 2-bromo-2, 2-dinitroethyl acetate with bases | |
US3751462A (en) | Process for preparation of substituted fluoromethanesulfonanilides | |
US2668176A (en) | Dinitrobutyrates | |
SU469251A3 (en) | The method of obtaining heterocyclic compounds | |
SU1402601A1 (en) | Method of producing 8-mercapto-1-methyl-2-methylthiohypoxanthine | |
SU429062A1 (en) | A method for producing pyrido [2,3-b] [1,5] tiazepinones A method is proposed for producing pyrido [2,3-th] [! 1,5] thiazepiones that can be used as biologically active substances. derivatives of said heterocyclic system. Only derivatives of pyrimido [i2,5- &] ['1,5] thiazepinone are known, the preparation of which is based on the reaction of 5-amino-6-mercaptopyrimidines with p-bromopropionic acid chloride, followed by cyclization of the 5- (p-bromopropionyl) amino-6-mercaptopyrimidines and pyrimidothiazepines. It turned out that pyridothiazepinones could not be obtained by this method, since the reaction of 2-mercapto-3-aminopyridines with p-bromo-ropionic acid chloride proceeded simultaneously to the production of 4-bromine | resulting in the formation of compounds from which It is not possible to switch to pyridothiazepinones. A method is proposed for obtaining irido [2,3-6] [1,5] thiazepinones of the general formula 1Ri,, I ^ ', N— <where R is hydrogen, alkoxyl or halo; RI is hydrogen or alkyl. The method consists in that 2-mercapto-3-aminopyridine of the general formula 2IN'H, SH1015, where R has the indicated values, reacts with p-halogenoalkanoic acid in an environment of a solvent, for example an alcohol, in the presence of alkali metal hydroxides, thus obtained 2- (| p-Carboxyethyl) thio-3-aminopyridine of the general formula 320 and f ^^^^ - I II g - COOH-s - ^ 2530 The resulting compounds of Formula 1, where Ri is hydrogen, are either isolated by conventional administration or, if necessary, further converted into the desired compounds of general formula 1, wherein Ri • - alkyl, haloalkyl action, e.g. | |
SU554811A3 (en) | The method of obtaining methylsulfonyl derivatives | |
SU503408A1 (en) | The method of obtaining symmetric unsubstituted in the chain of hexa - or heptacarbocyanine dyes |